2.2.6. Type of outcome measurements
This protocol is extracted from research article:
Chinese herbal medicine injections (CHMIs) for chronic pulmonary heart disease
Medicine (Baltimore), Jan 22, 2021; DOI: 10.1097/MD.0000000000024128

Markedly effective rate (MER) and the total effective rate (TER);

QoL obtained from the corresponding scale;

Adverse events.

New York Heart Association (NYHA) classification;

Left ventricular ejection fraction (LVEF);

Mean pulmonary artery pressure (mPAP);

B-type natriuretic peptide (BNP);

Hemorrheology assessment, the hemorrheology index includes whole blood viscosity (WBV), plasma viscosity (PV), hematocrit, erythrocyte aggregation index (EAI) and content of fibrinogen (FBG);

Blood gas analysis, the blood gas indicator contains partial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2), saturation of hemoglobin with oxygen (SaO2) and pH value.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.